Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approach.

Alexandre Acramel Sandy Blondeel-GomesMathilde DupréOrnella Tangila KayembeAude RochereauLaurence Escalup Romain-Pacôme DesmarisNathalie JourdanAdeline CordaryPauline Vaflard Paul-Henri Cottu Audrey Bellesoeur

Published in: British journal of clinical pharmacology (2024)

Advanced prescription of injectable anticancer drugs appears to be a safe practice for patients when combined with risk management. The major risks identified concerned missed dose adjustment, prescription duplication and lack of consideration for abnormal biology data.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
primary care
papillary thyroid
peritoneal dialysis
prognostic factors
machine learning
data analysis
patient reported
lymph node metastasis